Integral Ad Science (NASDAQ:IAS - Get Free Report)'s stock had its "market perform" rating restated by investment analysts at Raymond James Financial in a research note issued to investors on Thursday,Benzinga reports.
Several other equities analysts have also issued reports on the stock. Barclays boosted their target price on shares of Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a report on Friday, August 8th. Stifel Nicolaus raised their price objective on shares of Integral Ad Science from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Tuesday, July 22nd. BMO Capital Markets set a $10.30 target price on Integral Ad Science and gave the company a "market perform" rating in a report on Wednesday. Craig Hallum cut Integral Ad Science to a "hold" rating in a report on Wednesday. Finally, Oppenheimer cut shares of Integral Ad Science from an "outperform" rating to a "market perform" rating in a research report on Wednesday. Three analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, Integral Ad Science presently has a consensus rating of "Hold" and a consensus price target of $13.25.
View Our Latest Report on Integral Ad Science
Integral Ad Science Stock Down 0.0%
Shares of Integral Ad Science stock traded down $0.01 on Thursday, hitting $10.19. The stock had a trading volume of 6,461,500 shares, compared to its average volume of 1,354,644. Integral Ad Science has a twelve month low of $6.26 and a twelve month high of $13.62. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of 29.96, a price-to-earnings-growth ratio of 1.20 and a beta of 1.57. The business's 50 day moving average is $8.65 and its two-hundred day moving average is $8.17.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.03. Integral Ad Science had a return on equity of 5.00% and a net margin of 9.79%.The firm had revenue of $149.20 million during the quarter, compared to the consensus estimate of $143.02 million. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities analysts predict that Integral Ad Science will post 0.26 earnings per share for the current fiscal year.
Insider Activity
In related news, CEO Lisa Utzschneider sold 9,922 shares of the firm's stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $8.12, for a total value of $80,566.64. Following the transaction, the chief executive officer directly owned 380,557 shares of the company's stock, valued at approximately $3,090,122.84. This trade represents a 2.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last ninety days, insiders have sold 35,073 shares of company stock worth $289,641. Insiders own 2.00% of the company's stock.
Institutional Investors Weigh In On Integral Ad Science
A number of hedge funds have recently bought and sold shares of IAS. DekaBank Deutsche Girozentrale bought a new position in shares of Integral Ad Science in the 1st quarter valued at about $42,000. State of Wyoming purchased a new position in shares of Integral Ad Science in the 4th quarter worth approximately $51,000. CWM LLC raised its holdings in Integral Ad Science by 1,248.1% during the 2nd quarter. CWM LLC now owns 9,019 shares of the company's stock valued at $75,000 after buying an additional 8,350 shares during the period. Tower Research Capital LLC TRC boosted its stake in Integral Ad Science by 136.5% during the second quarter. Tower Research Capital LLC TRC now owns 10,158 shares of the company's stock worth $84,000 after buying an additional 5,862 shares during the period. Finally, Virtu Financial LLC purchased a new stake in Integral Ad Science in the 1st quarter worth about $87,000. Hedge funds and other institutional investors own 95.78% of the company's stock.
About Integral Ad Science
(
Get Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.